Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?
暂无分享,去创建一个
[1] N. Hollenberg,et al. Literature alert , 2002 .
[2] Cardiac fibroblasts are predisposed to convert into myocyte phenotype: Specific effect of transforming growth factor β , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[3] B. Jugdutt. Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy. , 1993, The Canadian journal of cardiology.
[4] A. Luttun,et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.
[5] L. Leinwand,et al. Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. , 1989, Journal of molecular and cellular cardiology.
[6] J. Davies,et al. Molecular Biology of the Cell , 1983, Bristol Medico-Chirurgical Journal.
[7] R. Zak. Development and Proliferative Capacity of Cardiac Muscle Cells , 1974, Circulation research.
[8] B. Jugdutt. Left ventricular rupture threshold during the healing phase after myocardial infarction in the dog. , 1987, Canadian journal of physiology and pharmacology.
[9] R. Taylor,et al. Collagen synthesis and content in right ventricular hypertrophy in the dog. , 1981, The American journal of physiology.
[10] T. Ichiki,et al. Targeted Deletion of Angiotensin II Type 2 Receptor Caused Cardiac Rupture After Acute Myocardial Infarction , 2002, Circulation.
[11] B. Jugdutt. Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. , 2003, Current drug targets. Cardiovascular & haematological disorders.
[12] B. Jugdutt,et al. Functional impact of remodeling during healing after non-Q wave versus Q wave anterior myocardial infarction in the dog. , 1992, Journal of the American College of Cardiology.
[13] K. Weber,et al. Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.
[14] J. Covell. Factors influencing diastolic function. Possible role of the extracellular matrix. , 1990, Circulation.
[15] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.
[16] Douglas L Mann,et al. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.
[17] B. Brodsky,et al. The triple‐lielix motif in proteins , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] J. Woessner,et al. The Matrix Metalloproteinase Family , 1998 .
[19] M. Eghbali,et al. Collagen chain mRNAs in isolated heart cells from young and adult rats. , 1988, Journal of molecular and cellular cardiology.
[20] B. Pitt,et al. Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[21] Nag Ac,et al. Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. , 1980 .
[22] Peter Gaudron,et al. Progressive Left Ventricular Dysfunction and Remodeling After Myocardial Infarction Potential Mechanisms and Early Predictors , 1993, Circulation.
[23] B. Strauss,et al. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. , 2003, American journal of physiology. Heart and circulatory physiology.
[24] S. Factor,et al. Alterations of the myocardial skeletal framework in acute myocardial infarction with and without ventricular rupture. A preliminary report. , 1987, The American journal of cardiovascular pathology.
[25] F. Spinale,et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. , 2001, American journal of physiology. Heart and circulatory physiology.
[26] F. Alla,et al. Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES) , 2000, Circulation.
[27] B. Jugdutt,et al. Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models. , 1996, Circulation.
[28] S. Kumar,et al. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. , 1995, Journal of molecular and cellular cardiology.
[29] J. Cleutjens,et al. The role of matrix metalloproteinases in heart disease. , 1996, Cardiovascular research.
[30] D. Etherington. Collagen degradation , 1977, Connective tissue research.
[31] M. Eghbali,et al. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor beta. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Covell,et al. Increase in Cross‐Linking of Type I and Type III Collagens Associated With Volume‐Overload Hypertrophy , 1988, Circulation research.
[33] Identification of patients prone to infarct expansion by the degree of regional shape distortion on an early two–dimensional echocardiogram after myocardial infarction , 1990, Clinical cardiology.
[34] G Olivetti,et al. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. , 1990, Circulation research.
[35] B. Pitt,et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[36] A. Becker,et al. Remodeling after myocardial infarction in humans is not associated with interstitial fibrosis of noninfarcted myocardium. , 1997, Journal of the American College of Cardiology.
[37] S. Yusuf,et al. Effect of acute angiotensin converting enzyme inhibition on left ventricular diastolic filling in patients with congestive heart failure: Relation to right ventricular volume , 1990 .
[38] H. Matsubara,et al. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. , 1998, Circulation research.
[39] K. Weber,et al. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.
[40] J. Rouleau,et al. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat. , 1998, Circulation.
[41] E. Miller. Collagen structure and function , 1992 .
[42] S. Tyagi. Proteinases and myocardial extracellular matrix turnover , 1997, Molecular and Cellular Biochemistry.
[43] K. Weber,et al. Infarct scar: a dynamic tissue. , 2000, Cardiovascular research.
[44] A. Nag,et al. Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. , 1980, Cytobios.
[45] D. Mann,et al. Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. , 1998, Circulation.
[46] E. Antman,et al. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. , 1999, Journal of the American College of Cardiology.
[47] B. Jugdutt. Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension. , 1983, Circulation.
[48] E. Sonnenblick,et al. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ("stunned") but viable myocardium. , 1987, Journal of the American College of Cardiology.
[49] J. Foidart,et al. Matrix metalloproteinase family. , 1995, Cell biology international.
[50] T K Borg,et al. The collagen network of the heart. , 1979, Laboratory investigation; a journal of technical methods and pathology.
[51] U. Ryan,et al. Voltage-gated and receptor-mediated ionic currents in the membrane of endothelial cells. , 1989, Journal of molecular and cellular cardiology.
[52] C A Beltrami,et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. , 1994, Circulation.
[53] H. Schunkert,et al. Angiotensin‐Converting Enzyme Inhibition Prolongs Survival and Modifies the Transition to Heart Failure in Rats With Pressure Overload Hypertrophy Due to Ascending Aortic Stenosis , 1994, Circulation.
[54] B. Jugdutt,et al. Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post infarction pericarditis. Influence of other pharmacologic agents during early remodelling. , 1989, The Canadian journal of cardiology.
[55] P. Armstrong,et al. Remodeling and reparation of the cardiovascular system. , 1992, Journal of the American College of Cardiology.
[56] I. K. Cohen,et al. Wound Healing: Biochemical & Clinical Aspects , 1992 .
[57] B. Pitt,et al. EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 2003 .
[58] B. Jugdutt,et al. Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction. , 1997, Canadian Journal of Cardiology.
[59] M. Flather,et al. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. , 1995, Circulation.
[60] B. Jugdutt. Effect of reperfusion on ventricular mass, topography, and function during healing of anterior infarction. , 1997, The American journal of physiology.